AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 160 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $344,000 | +12.1% | 22,706 | -44.7% | 0.00% | – |
| Q2 2022 | $307,000 | -95.4% | 41,027 | -90.2% | 0.00% | -100.0% |
| Q2 2021 | $6,702,000 | -29.2% | 418,624 | -20.9% | 0.00% | -42.9% |
| Q1 2021 | $9,460,000 | +4492.2% | 529,366 | +7480.8% | 0.01% | – |
| Q2 2019 | $206,000 | -37.0% | 6,983 | +1.5% | 0.00% | – |
| Q1 2019 | $327,000 | -41.4% | 6,878 | -55.5% | 0.00% | -100.0% |
| Q4 2018 | $558,000 | -52.1% | 15,466 | -18.3% | 0.00% | 0.0% |
| Q3 2018 | $1,166,000 | -1.4% | 18,940 | +8.2% | 0.00% | 0.0% |
| Q2 2018 | $1,183,000 | +78.4% | 17,510 | +43.2% | 0.00% | 0.0% |
| Q1 2018 | $663,000 | -27.9% | 12,225 | -20.6% | 0.00% | 0.0% |
| Q4 2017 | $920,000 | +235.8% | 15,406 | +173.0% | 0.00% | – |
| Q3 2017 | $274,000 | -35.8% | 5,643 | -30.5% | 0.00% | – |
| Q2 2017 | $427,000 | – | 8,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |